Virbac (Virbac) Tax Provision

: $-65 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

Virbac's tax provision for the six months ended in Jun. 2023 was $-38 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2023 was $-65 Mil.

Virbac Tax Provision Historical Data

The historical data trend for Virbac's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Tax Provision

-23.17

-26.04

-40.49

-49.28

-58.95

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Tax Provision																-32.43	-18.86	-32.11	-26.77	-37.98

Virbac Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-65 Mil.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.